Steakholder Foods : Eat meat sustainably. Be a Steakholder - Form 6-K -Today at 05:18 pm
Eat meat sustainably. Be a Steakholder. September 6, 2023 Dear Shareholder, You are cordially...
Source: marketscreener.com
📰 Chief Technologies News
Chief Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chief Technologies. Real-time updates on events, politics, business and more.
PsiQuantum opens UK-based R&D site for high-power cryogenic systems
Californian quantum computing firm PsiQuantum has opened a UK-based advanced research and development (R&D) site to develop the ‘next generation’ of high-power cryogenic modules to scale photonic quantum computers to millions of qubits.
United States United Kingdom Mark Thompson Scitech Daresbury Michelle Donelan Technology Facilities Council
Source: gasworld.com
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
01.08.2022 - The addition of a U.S. site will allow SciSparc to accelerate trial recruitment and further development of novel treatments for patients in need TEL AVIV, Israel, Aug. 01, 2022 (GLOBE NEWSWIRE) - SciSparc Ltd. (Nasdaq: SPRC) (Company or ... Seite 1
Tel Aviv Michaelh Bloch Adi Zuloff Shani Yale University Child Study Center At Yale University Tel Aviv Sourasky Medical Center
Source: wallstreet-online.de
SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome
08.07.2022 - TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) - SciSparc Ltd. (Nasdaq: SPRC) (Company or SciSparc), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, ... Seite 1
Adi Zuloff Shani Yale University Child Trial Center At Yale University Child Trial Center Chief Technologies Yale Global Tic Severity Scale
Source: wallstreet-online.de
SciSparc Announces Expanding its Clinical Operations to
TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Tel Aviv Adi Zuloff Shani Yale University Scisparc Ltd Tel Aviv Sourasky Medical Center Hannover Medical School In
Source: globenewswire.com
Ferrari's Biggest Changes In Years Now Underway
Ferrari has laid the groundwork for some of the most significant changes it'll undergo in its 75-year histo...
Source: carbuzz.com
SciSparc to Commence a Pre-Clinical Study Using its SCI-210 Cannabidiol Based Treatment for Epilepsy
Share this article Share this article TEL AVIV, Israel, March 9, 2021 /PRNewswire/ -- SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.) (OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced it has entered an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Companys SCI-210 drug development program, a proprietary novel pharm...
Adi Zuloff Shani Exchange Commission Scisparc Ltd Sheba Fund For Health Services Therapix Biosciences Ltd Drug Administration
Source: prnewswire.com